FOX 25’s Bob Dumas reports on a study by MIT Medical that shows most parents could successfully perform strep tests at home. David Diamond, associate medical director of MIT Medical, explains that in the healthcare field, “we are empowering patients to help us take care of their health,” adding that this test, “would be yet another advance in this regard.”
Washington Post reporter Ben Guarino writes that a study by research scientist Nick Obradovich provides evidence that rising temperatures caused by climate change could increase the number of nights where people have difficulty sleeping. The researchers found that “increasing temperatures could add six additional restless nights per month per 100 people, and 14 nights by 2099.”
Writing for The Los Angeles Times, Deborah Netburn examines a study by MIT researchers that shows climate change could affect how well people sleep at night. “There are going to be lots and lots of impacts of climate change and this is just another factor in a mosaic of negative factors,” says research scientist Nick Obradovich.
A study by research scientist Nick Obradovich finds that increasing temperatures caused by climate change could impact sleep quality, particularly for the poor and elderly, reports Marlene Cimons for Popular Science. Obradovich explains that the study shows, “ambient temperature can play a role in disrupting sleep but also that climate change might make the situation worse by driving up rates of sleep loss.”
Wall Street Journal reporter James Hagerty writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation known for his work as a pioneering leader in the field of biotechnology.
Xconomy reporter Ben Fidler writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation who died at age 71. Institute Prof. Phillip Sharp explains that Termeer was, “a transformational leader in biotechnology of orphan diseases. Many children now have hope of a healthy life because of his vision and 40 years of creative business leadership.”
Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe. Termeer was, “a key leader in the biotech revolution that placed Massachusetts at the nexus of cutting-edge research and development.”
Reporting for the PBS NewsHour, Nsikan Akpan highlights a new study co-authored by MIT researchers that examines how many NIH grants lead to new patents and medications. Prof. Pierre Azoulay explains that the study, “provides evidence that the research done in the public sector is useful — it’s relevant for the research done by private-sector firms.”
Newsweek reporter Jessica Wapner writes about a new study by MIT researchers that provides evidence that NIH funding contributes to a large number of patents in the field of biomedicine. The findings indicate that NIH-funded research “is not being done in an ivory tower,” explains Prof. Pierre Azoulay. “Companies use it as input in their own discovery efforts.”
Nature reporter Elie Dolgin writes about Prof. Pierre Azoulay’s new research that shows NIH funding has a significant impact on innovation in the field of biomedicine. Azoulay explains that from an economic standpoint the U.S. is “under-investing overall” in biomedical research.
Los Angeles Times reporter Melissa Healy writes that a new study by Prof. Pierre Azoulay examining the impact of NIH-funded research shows that NIH funding, “fuels the kinds of innovations that drive the U.S. economy.” Azoulay explains, “NIH public funding expenditures have large effects on the patenting output of the private sector.”
A study by Prof. Pierre Azoulay demonstrates the significant impact of NIH funding on biomedical patents, reports Carolyn Johnson for The Washington Post. Azoulay explains, “if your view was that the research done by academics...[has] no ramifications for the real world and the development of new medicines — well, that view is not correct.”
MIT researchers have estimated that 1,200 people in Europe could die prematurely due to excess emissions from Volkswagen vehicles sold in Germany, reports Steph Yin for The New York Times. Research assistant Guillaume Chossière says that the study demonstrates why manufacturers should make nitrogen oxides emissions “as low as possible by allowing emissions-control devices to work properly.”
MIT researchers have found that pollution from Volkswagen vehicles rigged to pass vehicle emissions standards tests could lead to 1,200 premature deaths in Europe, according to the AFP. The researchers found that the excess pollution “corresponded to about 1.9 billion euros ($2 billion) in health costs and lost labor productivity.”
Boston Herald reporter Jordan Graham writes that MIT researchers have estimated that excess pollution from VW vehicles sold in Germany could lead to 1,200 premature deaths in Europe. Graham writes that the researchers found that the pollution “will likely lead to an increase in respiratory disease.”